Abstract
Anaplastic large cell lymphoma (ALCL) is a distinct type of CD30+ T/null-cell non-Hodgkin's lymphoma that frequently involves nodal and extranodal sites. The presence of leukemic phase in ALCL is extremely rare and occurs exclusively with ALK1-positive ALCL. We describe two patients with ALK1-positive ALCL who developed a leukemic phase with rapid progression of the disease. Immunophenotypic pattern assessed on peripheral blood by flow cytometry revealed CD45, CD30, and CD25 positivity in both cases but NPM-ALK1 was expressed in only one case. Both patients developed leukemic phase as a terminal event of the disease and we share the immunophenotypic features of both cases.
MeSH terms
-
Adolescent
-
Anaplastic Lymphoma Kinase
-
Child
-
Disease Progression
-
Female
-
Flow Cytometry
-
Humans
-
Interleukin-2 Receptor alpha Subunit / analysis
-
Ki-1 Antigen / analysis
-
Leukemia, Lymphoid / diagnosis*
-
Leukemia, Lymphoid / pathology*
-
Leukocyte Common Antigens / analysis
-
Leukocytes, Mononuclear / chemistry
-
Lymphoma, Large-Cell, Anaplastic / complications
-
Lymphoma, Large-Cell, Anaplastic / diagnosis*
-
Lymphoma, Large-Cell, Anaplastic / pathology*
-
Male
-
Receptor Protein-Tyrosine Kinases / metabolism*
Substances
-
IL2RA protein, human
-
Interleukin-2 Receptor alpha Subunit
-
Ki-1 Antigen
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases
-
Leukocyte Common Antigens
-
PTPRC protein, human